Sreedhar Sagi, MD

Dr. Sreedhar Sagi is the Head of Sandoz International Region (Asia-Pacific, Middle East, Africa, Latin America), a Novartis company. He oversees all Medical Affairs activities and is responsible for the Medical Affairs strategy and its implementation in the Sandoz International Region. Prior to his current role, he was Head of Safety Risk Management at Sandoz Global Headquarters in Germany, with responsibility for all Sandoz products worldwide, for Risk Management Plans and for Medical Risk Assessments for product quality issues. In a previous role, he was managing the Safety of Biosimilars, where he was responsible for the set-up, optimization and implementation of Safety Risk Management processes for Biosimilars at a global and national level. He has been with Sandoz/ Novartis since May 2007. He holds a Master's Degree in Pharmacy (Andhra University, India), and Master’s Degree in Biotechnology (Hochschule Mannheim, Germany), and a Ph.D. in Medical Biotechnology (Heidelberg University in Germany).